WCM
TXG icon

WealthTrak Capital Management’s 10x Genomics TXG Stock Holding History

WealthTrak Capital Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10
Closed -$116 – 827
2025
Q2 		$116 Sell
10
-5
-33% -$46 ﹤0.01% 912
2025
Q1 		$131 Sell
15
-5
-25% -$63 ﹤0.01% 912
2024
Q4 		$288 Buy
+20
New +$316 ﹤0.01% 730

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WealthTrak Capital Management's TXG Position: Q3 2025 in Review

WealthTrak Capital Management sold out of 10x Genomics (TXG) in Q3 2025, closing a stake of 10 shares — an estimated $116 sold.

WealthTrak Capital Management first reported a position in TXG in Q4 2024 and held it in 3 quarters. The position peaked at $288 in Q4 2024. 317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.

  • WealthTrak Capital Management reported no remaining 10x Genomics position as of Q3 2025 after selling out during the quarter.
  • WealthTrak Capital Management sold 10 10x Genomics shares in Q3 2025, an estimated $116.
  • WealthTrak Capital Management first reported a position in 10x Genomics in Q4 2024 and held it in 3 quarters.
  • WealthTrak Capital Management's 10x Genomics position peaked at $288 in Q4 2024.
  • 317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.

Based on WealthTrak Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.